Analyzing treatment options for brain hemorrhage
Analysis of Related Factors of Hematoma Morphology in Patients With Cerebral Hemorrhage and Prognosis Analysis of Different Regimens for Cerebral Hemorrhage
This study is trying to see how the shape of a brain bleed affects its growth and how different treatments can help patients with cerebral hemorrhage.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | The Affiliated Hospital Of Guizhou Medical University Academic / other |
| Locations | 1 site (Guiyang, Guizhou) |
| Trial ID | NCT05548530 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate how early hematoma morphology affects hematoma expansion in patients with cerebral hemorrhage. By analyzing clinical data and imaging results, the study seeks to optimize treatment plans and improve patient outcomes. It will explore the effectiveness of various surgical interventions, including stereotactic hematoma puncture, decompressive craniectomy, and neuroendoscopic techniques. The goal is to provide insights that can guide clinical practice in managing this serious condition.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-80 diagnosed with intracerebral hemorrhage via head CT.
Not a fit: Patients with multiple intracranial hemorrhages or those whose hemorrhage is due to tumors, trauma, or other lesions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies that reduce mortality and enhance recovery for patients with cerebral hemorrhage.
How similar studies have performed: While there have been studies on treatment options for cerebral hemorrhage, this specific approach focusing on hematoma morphology and its impact on treatment efficacy is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-80 years old; 2. Intracerebral hemorrhage was diagnosed by head CT examination; Exclusion Criteria: 1. Multiple intracranial hemorrhage; 2. Intracranial hemorrhage caused by intracranial tumor, aneurysm, trauma, infarction or other lesions; 3. Coagulation disorders or a history of taking anticoagulants; 4. Infectious meningitis, systemic infection; 5. History of severe stroke, heart, kidney, liver and lung dysfunction in the past; 6. Severe brain herniation (mydriasis, respiratory and circulatory failure); 7. Incomplete or missing basic data or follow-up information in the hospital.
Where this trial is running
Guiyang, Guizhou
- Guizhou Medical University Affiliated Hospital — Guiyang, Guizhou, China (Recruiting)
Study contacts
- Study coordinator: Wu guofeng, Doctor
- Phone: 13809431723
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.